drugset / Trial / NCT03691038

Comparison of Conventional Dose Regimen and New Dose Regimen of Pregabalin

NCT03691038

Terminated 10 enrolled Kangbuk Samsung Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to propose a new flexible dose regimen starting from 75mg using the low dose pregabalin 25 mg and 50 mg comparing the side effect and compliance with the conventional flexible dose regimen staring from 150mg using the pregabalin 75mg.

Timeline

Start
2018-10-10
Primary completion
2019-10-30
Completion
2019-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 25 mg
Comparator Pregabalin Small molecule 50 mg
Comparator Pregabalin Small molecule 75 mg

Indications